Vectura Gets $10M Added To $90M Inhaler IP Award
A Delaware federal judge on Thursday granted British pharma company Vectura's request for $10.5 million in supplemental damages in a case in which a jury found GlaxoSmithKline willfully infringed a patent...To view the full article, register now.
Already a subscriber? Click here to view full article